I N T R O D U C T I O N
Cytochalasin B, a mold metabolite, has been shown to inhibit cytokinesis and motility (3), morphogenie development (18) , endocytosis (5) , and the transport of sugars (8) (9) (10) 12) . It has also been demonstrated that this drug inhibits the stimuatcd elaboration of extracellular substances from glands--the release of thyroxine from the thyroid gland after stimulation by thyroid-stimulating hormone (TSH) (19) , and the release of o~-amylase from the parotid gland after stimulation by epinephrine (1) .
To date, the effects of cytochalasin B on other aspects of hormone-mediated responses have not been reported. Therefore, studies were initiated to study the effects of the drug on another hormonemodified system--the induction of tyrosine aminotransferase (E.C. 2.6.1.5) by insulin, cortisol, or N6-2CO-dibutyryl adenosine-31-5r-cyclic monophosphate. These studies were carried out with Reuber hepatoma (H-35) cells grown in culture.
M A T E R I A L S A N D M E T H O D S
Reubcr hepatoma (H-4-II-E, also referred to as H-35) cells were cultured in Swim's 77 modified medium as a nonconfluent monolayer according to the previously published procedure (2) . The H-35 cells were used in these experiments when they were in a mid-log phase of growth. The cells were incubated with insulin (0.5 #g/ml), cortisol (50 #M final concentration), or dibutyryl cyclic AMP (0.5 mM final concentration), dissolved in either Swim's 77 or 0.16 M NaC1 for 6 or 4 h before their harvest and the preparation of cell extracts (2) . In all experiments, the H-35 cells were incubated with dimethyl sulfoxide (DMSO) or cytochalasin B, dissolved in a corresponding amount of DMSO, for 30 rain at 37°C in Swim's 77 medium before the addition of the hormones or cyclic nucleotide.
Tyrosine aminotransferase (TAT) was assayed by the procedure of Diamondstone (6) 
RESULTS

AND DISCUSSION
Induction of Tyrosine Aminotransferase
Cytochalasin B (50 ]zg/ml of culture medium) completely inhibited the induction of TAT by either insulin or cortisol (Table I) . At a concentration of l0 ~g/ml, the drug inhibited the hormone-induced effect to a small but significant extent. At a concentration of 1.0 jzg/ml, cytochalasin B was without effect on the hormoneinducible levels of TAT.
Dibutyryl cyclic AMP, at a concentration of 500 ]~M, induced the formation of TAT (Table I) . However, unlike its inhibition of the insulin and cortisol induction of TAT, cytochalasin B had no effect on the cyclic AMP inducing system.
The synthesis of new enzyme is implicit in the hormone and cyclic AMP induction of tyrosine aminotransferase. However, since we have found a At the end of the preincubation period, insulin at 0.5 /zg/ml, cortisol to a concentration of 50 /~M, or dibutyryl cyclic AMP (DBC-AMP) to a concentration of 0.5 nlM was added, and the hepatoma cells were incubated for 6 h (experiment 1) or 4 h (experiments 2 and 3). After incubation, the plates were rinsed with Swim's 77 medium, and a cell extract was prepared. The results are the mean 4-SE of three to four plates per point. differential inhibition by cytochalasin B on the induction of this enzyme, it would seem unlikely that the failure to induce the formation of enzyme is the result of an inhibition of protein synthesis. In support of this conclusion, it was found that incubation of H-35 cells for 3.5 h with cytochalasin B at a concentration (20 gg/ml, experiment 3 in Table I ) that produced a significant inhibition of enzyme induction did not inhibit the incorporation of a 30 min pulse of radiolabeled leucine (data not presented). This observation is in agreement with those of others (7, 15) using different cell lines, but does not agree with the data of Springer and Perdu0, who found a 20 % decrease in amino acid incorporation during a 1 h incubation with the drug in cultured chick embryo fibroblasts. Another possible explanation for the effect of cytochalasin B on hormone versus cyclic AMP induction of tyrosine aminotransferase could be through a differential uptake or binding of insulin or cortisol compared with that of the nucleotide.
Binding and Uptake of Insulin, Cortisol, and Cyclic AMP
Cytochalasin B, at concentrations of 1-20 #g/ml, di:l not inhibit the binding and subsequent uptake I Springer, A., and J. F. Perdue. Manuscript submitted for publication. of insulin, cortisol, or cyclic AMP (Table II) . The cells incubated in dimethyl sulfoxide had levels of hormone binding which were comparable to that observed for untreated cells (Table II) . No attempt was made to determine whether the radioactivity taken up was still in the form of the parent compound.
The active transport of sugars across the cell membrane represents one plasma membraneassociated system which is very sensitive to environmental conditions, such as pH, serum levels, and the degree of cell confluency (4, 14) . This system is also sensitive to cytochalasin B. Kletzien et al. (9) and Kletzien and Perdue (10) found that at a concentration of 70 ng/ml, 50 percent of 2-deoxy-D-glucose uptake was inhibited. At this concentration of metabolite, there were no detectable changes in cell shape.
It may be inferred from this work (9, 10) that minor perturbations of the membrane-cell cortex regions brought about by local depolymerization of microfilaments or microtubules could influence plasma membrane functions. In this regard, Ukena and Berlin (16) have found that treating polymorphonuclear leukocytes with colchicine or vinblastine, drugs which depolymerize microtubules, disrupted the geographically separated plasma membrane functions of phagocytosis and adenine and lysine transport. However, the hy-pothesis of drug-initiated depolymerizations of elements of the cytoskeleton influencing cell membrane functions cannot be generalized for all cell processes. In Chang liver cells, cytochalasin B altered their shape but it had no inhibiting effect on the basal or fluoride or isoproterenol stimulated levels of adenyl cyclase (data not presented). Furthermore, cytochalasin B, although a potent and competitive inhibitor of sugar transport, was only weakly inhibitory toward the uptake of amino acids and thymidine (12) 1 or of inorganic phosphate 2, and had no effect on choline transport (8) .
One explanation for the differential cytochalasin B inhibition of tyrosine aminotransferase induction by the hormones versus cyclic AMP takes into account the role of microfilaments and microtubules in maintaining cell membrane architecture and cell shape. Puck et al. (13) It is conceivable that cytochalasin B prevents the induction of tyrosine aminotransferase by the hormones through a mechanism of microfilament depolymerization with concomitant membrane perturbations and rearrangements. Cyclic AMP promotes the assembly of microtubules and possibly microfilaments. As such, exogenous levels of this compound could become antagonists to the effects of cytochalasin B on depolymerization and thereby permit the nucleotide to function in its Warner, D., and J. F. Perdue. Unpublished observations.
other roles, including the induction of tyrosine aminotransferase.
SUMMARY
Cytochalasin B inhibited the induction of tyrosine aminotransferase (E.C. 2.6.1.5) by insulin and cortisol in Reuber H-35 hepatoma cells. The induction of this enzyme by dibutyryl cyclic AMP was not inhibited by cytochalasin B.
